ArticleFrontiers in immunology2026
Noninvasive immune-inflammatory profiling by ultrasound radiomics for preoperative prediction of central lymph node metastasis in papillary thyroid carcinoma.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Central lymph node metastasis in clinically node-negative papillary thyroid carcinoma is regulated by the tumor immune microenvironment, yet existing studies have addressed molecular, systemic immune, and local imaging signals in isolation without examining their cross-scale associations. Methods: A retrospective cohort of 1,000 cN0 PTC patients was enrolled. BRAF V600E mutation status, six peripheral blood immune-inflammatory indices, and an ultrasound radiomics deep learning score were integrated into four progressive LightGBM models. Cross-scale Spearman correlations, BRAF-stratified Fisher z-transformation tests, and TCGA-THCA immune deconvolution analysis were performed. Results: The three-scale integrated model achieved a validation AUC of 0.824, with all DeLong incremental comparisons reaching statistical significance. The DLR-score was significantly correlated with all six immune-inflammatory indices after Bonferroni correction. BRAF-positive subgroup exhibited significantly stronger imaging-immune coupling for NLR and SII, and this enhanced coupling persisted after adjustment for age, tumor size, multifocality, and Hashimoto's thyroiditis in partial correlation analyses. TCGA tissue immune infiltration patterns were directionally consistent with peripheral observations. Calibration assessment confirmed probability accuracy across the predicted range, and decision curve analysis demonstrated sustained net benefit superiority of the integrated model over single-scale alternatives within the clinically relevant 10% to 50% threshold interval. Conclusion: Three-scale noninvasive immune signals provide complementary CLNM prediction and exhibit directionally consistent cross-scale statistical associations at the correlation level, suggesting that they may serve as noninvasive surrogates reflecting partially overlapping aspects of the same tumor immune dysregulation process, although confirmation of the underlying biological mechanisms requires prospective studies incorporating direct tissue-level immune profiling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.